(1RS)-9-fluoro-1-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-benzo[1,4]thiazin-6-yl)-oxazolidin-5-yl]-propylamine}-1,2-dihydro-pyrrolo[3,2,1-ij]quinolin-4-one | 1220976-26-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: (1RS)-9-fluoro-1-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-benzo[1,4]thiazin-6-yl)-oxazolidin-5-yl]-propylamine}-1,2-dihydro-pyrrolo[3,2,1-ij]quinolin-4-one
• 英文别名: (1RS)-9-fluoro-1-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-benzo[1,4]thiazin-6-yl)-oxazolidin-5-yl]-propylamino}-1,2-dihydro-pyrrolo[3,2,1-ij]quinolin-4-one；(5R)-5-[3-[(5-fluoro-11-oxo-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12),9-tetraen-3-yl)amino]propyl]-3-(3-oxo-4H-1,4-benzothiazin-6-yl)-1,3-oxazolidin-2-one
• CAS: 1220976-26-0
• 化学式: C₂₅H₂₃FN₄O₄S
• 分子量: 494.546
• InChiKey: OODJPMXNQZTABC-VTBWFHPJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  35
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  116
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  (1RS)-9-fluoro-1-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-benzo[1,4]thiazin-6-yl)-oxazolidin-5-yl]-propylamine}-1,2-dihydro-pyrrolo[3,2,1-ij]quinolin-4-one 在 二乙胺 作用下， 以 乙醇 、 乙腈 为溶剂， 以100%的产率得到
  参考文献：
  名称：

  [EN] TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS
  [FR] COMPOSÉS ANTIBIOTIQUES OXAZOLIDINONE TRICYCLIQUE

  摘要：

  该发明涉及式(I)的抗菌化合物，其中“-----”是键或不存在，V是CH，CR 6或N; R 0是H或如果“-----”是键，则也可以是烷氧基; R 1主要是H或卤素; 当“-----”是键时，U是CH或N，或者如果“-----”不存在，则U是CH 2，NH或NR 9; R 2是H，烷基羰基或-CH 2 -R 3; R 3是H，烷基或羟基烷基; R 4是H或如果n不为0且R 5为H，则也可以是OH; R 5是H，烷基，羟基烷基，氨基烷基，烷氧基烷基，羧基或烷氧羰基; R 6是羟基烷基，羧基，烷氧羰基或-(CH 2 ) q -NR 7 R 8，其中q为1、2或3，且R 7和R 8中的每一个独立地是H或烷基，或R 7和R 8与携带它们的N原子形成一个环; R 9是烷基或羟基烷基; A是-(CH 2 ) p-，-CH 2 CH 2 CH(OH)-或-COCH 2 CH(OH)-; G是取代苯基或G 1或G 2，其中Q是O或S，X是CH或N; Y 1、Y 2和Y 3每个可以是CH或N; 当A为-CH 2 CH 2 CH(OH)-或-COCH 2 CH(OH)-时，n为0，当A为-(CH 2 ) p-，p为1、2、3或4时，n为0、1或2，但n和p的总和为2、3或4; 以及这些化合物的盐。

  公开号：

  WO2010041194A1

文献信息

• TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS
  申请人：Hubschwerlen Christian

  公开号：US20110195961A1

  公开（公告）日：2011-08-11

  The invention relates to antibacterial compounds of formula I wherein is a bond or is absent, V is CH, CR 6 or N; R 0 is H or, if is a bond, may also be alkoxy; R 1 is notably H or halogen; U is CH or N when is a bond, or, if is absent, U is CH 2 , NH or NR 9 ; R 2 is H, alkylcarbonyl or —CH 2 —R 3 ; R 3 is H, alkyl or hydroxyalkyl; R 4 is H or, if n is not 0 and R 5 is H, may also be OH; R 5 is H, alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, carboxy or alkoxycarbonyl; R 6 is hydroxyalkyl, carboxy, alkoxycarbonyl or —(CH 2 ) q —NR 7 R 8 , q being 1, 2 or 3 and each of R 7 and R 8 independently being H or alkyl or R 7 and R 8 forming with the N atom bearing them a ring; R 9 is alkyl or hydroxyalkyl; A is —(CH 2 ) p —, —CH 2 CH 2 CH(OH)— or —COCH 2 CH(OH)—; G is substituted phenyl or G 1 or G 2 wherein Q is O or S and X is CH or N; and Y 1 , Y 2 and Y 3 may each be CH or N; and n is 0 when A is —CH 2 CH 2 CH(OH)— or —COCH 2 CH(OH)—, and n is 0, 1 or 2 when A is —(CH 2 ) p —, p being 1, 2, 3 or 4, with the proviso that the sum of n and p is then 2, 3 or 4; and to salts of such compounds.

  该发明涉及式I的抗菌化合物，其中： - 当V为CH或N时，U为CH或N，R1为H或卤素，R2为H、烷基羰基或—CH2—R3，R3为H或烷基羟基，R4为H或OH（当n不为0且R5为H时），R5为H、烷基、羟基烷基、氨基烷基、烷氧基烷基、羧基或烷氧羰基，R6为羟基烷基、羧基、烷氧羰基或—( )q—NR7R8，其中q为1、2或3，且R7和R8各自独立地为H或烷基，或者R7和R8与它们所带的N原子形成一个环； - 当V为CR6时，U为 、NH或NR9，R0为H或烷氧基，R1为H或卤素，R2为H、烷基羰基或— —R3，R3为H或烷基羟基，R4为H或OH（当n不为0且R5为H时），R5为H、烷基、羟基烷基、氨基烷基、烷氧基烷基、羧基或烷氧羰基，R6为羟基烷基、羧基、烷氧羰基或—( )q—NR7R8，其中q为1、2或3，且R7和R8各自独立地为H或烷基，或者R7和R8与它们所带的N原子形成一个环； - 当V为一条键时，U为CH或N，R0为H或烷氧基，R1为H或卤素，R2为H、烷基羰基或— —R3，R3为H或烷基羟基，R4为H或OH（当n不为0且R5为H时），R5为H、烷基、羟基烷基、氨基烷基、烷氧基烷基、羧基或烷氧羰基，R6为羟基烷基、羧基、烷氧羰基或—( )q—NR7R8，其中q为1、2或3，且R7和R8各自独立地为H或烷基，或者R7和R8与它们所带的N原子形成一个环；A为—( )p—、— CH(OH)—或—CO CH(OH)—，G为取代苯基或G1或G2，其中Q为O或S，X为CH或N，Y1、Y2和Y3各自可以为CH或N；n当A为— CH(OH)—或—CO CH(OH)—时为0，当A为—( )p—时，n为0、1或2，p为1、2、3或4，但n和p的和必须为2、3或4；以及这些化合物的盐。
• Tricyclic oxazolidinone antibiotic compounds
  申请人：Hubschwerlen Christian

  公开号：US09346804B2

  公开（公告）日：2016-05-24

  The present invention relates to antibacterial compounds of formula (I) wherein “----” is a bond or is absent, V is CH, CR6 or N; R0 is H or, if “----” is a bond, may also be alkoxy; R1 is cyano, alkyl, or ethynyl; U is CH or N when “----” is a bond, or, if “----” is absent, U is CH2, NH or NH9; R2 is H, alkylcarbonyl or CH2—R3; R3 is H, alkyl or hydroxyalkyl; R4 is H or, if n is not 0 and R5 is H, may also be OH; R5 is H, alkyl, hydroxyalkyl, aminoalkyl, alkoxyalkyl, carboxy or alkoxycarbonyl; R6 is hydroxyalkyl, carboxy, alkoxycarbonyl or —(CH2)q—NR7R8, q being 1, 2 or 3 and each of R7 and R8 independently being H or alkyl or R7 and R8 forming with the N atom bearing them a ring; R9 is alkyl or hydroxyalkyl; A is —(CH2)p—, —CH2CH2CH(OH)— or —COCH2CH(OH)—; G is substituted phenyl or G1 or G2, wherein Q is O or S and X is CH or N; and Y1, Y2 and Y3 may each be CH or N; and n is 0 when A is —CH2CH2CH(OH)— or —COCH2CH(OH)—, and n is 0, 1 or 2 when A is —(CH2)p—, p being 1, 2, 3 or 4, with the proviso that the sum of n and p is then 2, 3 or 4; and to salts of such compounds.

  本发明涉及具有以下式（I）的抗菌化合物，“----”表示键合或不存在，V为CH，CR6或N；R0为H或，如果“----”为键合，则也可以为烷氧基；R1为氰基，烷基或乙炔基；当“----”为键合时，U为CH或N，如果“----”不存在，则U为CH2，NH或NH9；R2为H，烷基羰基或 —R3；R3为H，烷基或羟基烷基；R4为H或，如果n不为0且R5为H，则也可以为OH；R5为H，烷基，羟基烷基，氨基烷基，烷氧基烷基，羧基或烷氧羰基；R6为羟基烷基，羧基，烷氧羰基或—（ ）q—NR7R8，其中q为1、2或3，R7和R8各自独立地为H或烷基，或R7和R8与它们所带的N原子形成环；R9为烷基或羟基烷基；A为—（ ）p—，— CH（OH）—或—CO CH（OH）—；G为取代苯基或G1或G2，其中Q为O或S，X为CH或N；Y1、Y2和Y3可以分别为CH或N；当A为— CH（OH）—或—CO CH（OH）—时，n为0，当A为—（ ）p—时，n为0、1或2，p为1、2、3或4，但n和p的总和为2、3或4；以及这些化合物的盐。
• Lubricant Compositions Comprising Epoxide Compounds
  申请人：BASF SE

  公开号：US20140142009A1

  公开（公告）日：2014-05-22

  A lubricant composition including an epoxide compound is disclosed. An additive package including the epoxide compound is also disclosed. The epoxide compound of the lubricant composition acts to improve compatibility of the lubricant composition with a fluoropolymer seal and improve the total base number of the lubricant composition.
• LUBRICANT COMPOSITIONS COMPRISING EPOXIDE COMPOUNDS
  申请人：BASF SE

  公开号：US20170029737A1

  公开（公告）日：2017-02-02

  A lubricant composition including an epoxide compound is disclosed. An additive package including the epoxide compound is also disclosed. The epoxide compound of the lubricant composition acts to improve compatibility of the lubricant composition with a fluoropolymer seal and improve the total base number of the lubricant composition.
• Lubricant Composition
  申请人：BASF SE

  公开号：US20190322958A1

  公开（公告）日：2019-10-24

  A lubricant composition includes a base oil and an additive package. The additive package includes a seal compatibility additive chosen from a halide seal compatibility additive, an epoxide seal compatibility additive, a boroxine seal compatibility additive, a sulfonate ester seal compatibility additive, and combinations thereof. The alkoxylated amide and the ester are set forth in general formulas A and B, respectively: In general formulas A and B, each R 13 , R II , R III , and R IV , is, independently, a linear or branched, saturated or unsaturated, hydrocarbyl group. In addition, at least one of R II and R III include an alkoxy group, and R IV includes an amine group.